Clinical Trial Update: Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of prefixed liquid etanercept (Yisaipu) for active ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Prefilled Liquid Etanercept (Yisaipu) (etanercept)

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED